Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 58 pages
Exam (elaborations)

APEA 3P (Pathophysiology, Pharmacology, Physical Assessment) Test Bank — Version 3 Comprehensive Examination Questions for Advanced Practice Nursing Certification

Document preview thumbnail
Preview 4 out of 58 pages

APEA 3P (Pathophysiology, Pharmacology, Physical Assessment) Test Bank — Version 3 Comprehensive Examination Questions for Advanced Practice Nursing Certification

Content preview

APEA 3P (Pathophysiology, Pharmacology, Physical Assessment)
Test Bank — Version 3

Comprehensive Examination Questions for Advanced Practice Nursing
Certification

Enhanced Difficulty: Complex Clinical Scenarios & Integrated Decision-
Making



SECTION A: PATHOPHYSIOLOGY — Advanced Cellular Mechanisms &
Systemic Disorders (Questions 1–20)

1. A 58-year-old patient with long-standing type 2 diabetes mellitus presents with progressive
bilateral lower extremity paresthesias and burning pain that worsens at night. Neurological
examination reveals diminished vibratory sensation in the toes bilaterally, decreased ankle reflexes,
and intact motor strength. Which of the following pathophysiological mechanisms is MOST directly
responsible for this patient's distal symmetric polyneuropathy?

A. Microvascular ischemia of the vasa nervorum due to advanced glycation end-product deposition
B. Demyelination of peripheral nerves mediated by autoimmune T-cell infiltration
C. Toxic accumulation of sorbitol and fructose within Schwann cells due to aldose reductase activation
D. Axonal degeneration secondary to impaired axoplasmic transport from decreased nerve growth
factor
E. Inflammatory vasculitis of epineurial arterioles with subsequent axonal necrosis

Correct Answer: A — Microvascular ischemia of the vasa nervorum due to advanced glycation end-
product deposition

Rationale: Diabetic peripheral neuropathy is primarily a microvascular complication. Chronic
hyperglycemia leads to advanced glycation end-product (AGE) formation, which deposits in the vasa
nervorum, causing endothelial dysfunction, luminal narrowing, and ischemia of the endoneurial
capillaries. This results in axonal degeneration and segmental demyelination. While the polyol pathway
(sorbitol accumulation) contributes, microvascular ischemia is the primary mechanism. The neuropathy
is length-dependent, affecting longest nerves first (distal lower extremities), with sensory symptoms
(pain, paresthesia) preceding motor involvement. The clinical presentation of burning pain worse at
night with impaired vibratory sensation and diminished reflexes is classic for diabetic distal symmetric
polyneuropathy. Motor strength is typically preserved until late stages, as seen in this patient.

,2. A 72-year-old patient with a 45-pack-year smoking history presents with progressive shortness of
breath, chronic productive cough, and unintentional weight loss of 15 pounds over 6 months. Chest
examination reveals hyperresonance to percussion, decreased tactile fremitus, and distant breath
sounds with prolonged expiration. Arterial blood gas on room air shows pH 7.38, PaCO2 48 mmHg,
PaO2 62 mmHg, HCO3 28 mEq/L. Which combination of pathophysiological mechanisms BEST
explains this patient's clinical presentation?

A. Alveolar wall destruction with loss of elastic recoil, airway obstruction from mucous gland
hyperplasia, and hypoxemic vasoconstriction leading to pulmonary hypertension
B. Granulomatous inflammation of airways with caseating necrosis, bronchial wall thickening, and
right-to-left shunting through arteriovenous malformations
C. Bronchiolar smooth muscle hypertrophy from chronic allergen exposure, airway remodeling with
subepithelial fibrosis, and hyperinflation with air trapping
D. Alveolar-capillary membrane thickening with interstitial fibrosis, restrictive physiology with
decreased lung volumes, and diffusion impairment
E. Bronchial wall destruction from recurrent infections, saccular bronchiectasis with copious purulent
sputum, and hemoptysis from eroded bronchial arteries

Correct Answer: A — Alveolar wall destruction with loss of elastic recoil, airway obstruction from
mucous gland hyperplasia, and hypoxemic vasoconstriction leading to pulmonary hypertension

Rationale: This patient presents with classic clinical features of chronic obstructive pulmonary disease
(COPD), specifically the emphysema phenotype with hyperinflation (barrel chest, hyperresonance) and
chronic bronchitis (productive cough). The pathophysiological triad involves: (1) alveolar wall
destruction from protease-antiprotease imbalance and oxidative stress, causing loss of elastic recoil
and air trapping; (2) airway obstruction from mucous gland hypertrophy and hyperplasia with
increased mucus production; and (3) chronic hypoxemia (PaO2 62 mmHg) and hypercapnia (PaCO2 48
mmHg) from ventilation-perfusion mismatch. The compensated respiratory acidosis (pH 7.38 with
elevated HCO3 28) indicates chronic CO2 retention. Hypoxic pulmonary vasoconstriction leads to
pulmonary hypertension and eventual cor pulmonale. The mild elevation in PaCO2 with near-normal
pH represents chronic respiratory acidosis with renal compensation, typical of advanced COPD.




3. A 45-year-old female with systemic lupus erythematosus (SLE) presents with a 3-day history of
progressive dyspnea, pleuritic chest pain, and non-productive cough. She has a temperature of
38.2°C and oxygen saturation of 91% on room air. Chest radiograph shows bilateral interstitial
infiltrates without effusion. Laboratory studies reveal lymphopenia and elevated anti-dsDNA
antibodies. Which of the following immune-mediated mechanisms is MOST directly responsible for
the pulmonary findings in this patient?

A. Type I hypersensitivity with IgE-mediated mast cell degranulation causing acute bronchospasm and
pulmonary eosinophilia
B. Type II hypersensitivity with anti-glomerular basement membrane antibodies causing alveolar
hemorrhage and diffuse alveolar damage
C. Type III hypersensitivity with immune complex deposition in alveolar capillaries activating
complement and recruiting neutrophils

,D. Type IV hypersensitivity with CD8+ T-cell-mediated alveolar epithelial injury and granuloma
formation
E. Type V hypersensitivity with autoantibody-mediated stimulation of alveolar macrophages producing
profibrotic cytokines

Correct Answer: C — Type III hypersensitivity with immune complex deposition in alveolar
capillaries activating complement and recruiting neutrophils

Rationale: Acute lupus pneumonitis is a Type III hypersensitivity reaction characterized by immune
complex deposition in pulmonary capillaries, activating the complement cascade, generating C3a and
C5a anaphylatoxins, and recruiting neutrophils. The resulting inflammatory response causes alveolar-
capillary membrane injury, increased permeability, and interstitial infiltrates. The clinical presentation
includes fever, pleuritic chest pain, dyspnea, and hypoxemia. This is a life-threatening complication of
SLE with significant mortality. Lymphopenia is common in active SLE, and elevated anti-dsDNA
antibodies indicate increased disease activity. Type I hypersensitivity mediates allergic reactions; Type II
involves antibody-mediated cytotoxicity (Goodpasture's); Type IV is T-cell-mediated (sarcoidosis,
tuberculosis); Type V involves receptor stimulation (Graves' disease). The combination of active SLE,
elevated anti-dsDNA, bilateral interstitial infiltrates, and pleuritic chest pain is highly characteristic of
acute lupus pneumonitis.




4. A 68-year-old patient with a history of ischemic cardiomyopathy and ejection fraction of 25%
presents with progressive exertional dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.
Despite optimal medical therapy with ACE inhibitor, beta-blocker, and loop diuretic, his symptoms
have worsened over the past month. Physical examination reveals jugular venous distension at 14
cm H2O, a prominent S3 gallop, and bilateral crackles to the mid-scapulae. Laboratory studies show
BNP 1,200 pg/mL, serum sodium 132 mEq/L, and creatinine 1.8 mg/dL. Which of the following
pathophysiological mechanisms BEST explains the development of the hyponatremia in this patient
with decompensated heart failure?

A. Decreased glomerular filtration rate leading to impaired free water excretion and dilutional
hyponatremia
B. Excessive diuretic use causing salt wasting and total body sodium depletion
C. Increased aldosterone secretion promoting sodium reabsorption with secondary water retention
and relative sodium dilution
D. Syndrome of inappropriate antidiuretic hormone (SIADH) from ectopic ADH production by failing
myocardium
E. Decreased effective arterial volume stimulating baroreceptors, increasing non-osmotic vasopressin
release, and impairing water excretion

Correct Answer: E — Decreased effective arterial volume stimulating baroreceptors, increasing non-
osmotic vasopressin release, and impairing water excretion

Rationale: Hyponatremia in heart failure is primarily caused by decreased effective arterial volume,
which stimulates carotid and aortic baroreceptors, leading to non-osmotic vasopressin (ADH) release
from the posterior pituitary. This results in excessive free water reabsorption in the collecting ducts,

, causing dilutional hyponatremia. The impaired cardiac output leads to decreased renal perfusion,
activating the renin-angiotensin-aldosterone system and sympathetic nervous system, further
contributing to fluid retention. Despite total body sodium excess, serum sodium is diluted by excess
water. This is a poor prognostic sign in heart failure. Aldosterone promotes sodium reabsorption, but
the primary driver is ADH-mediated water retention. Diuretic use may worsen hyponatremia but is not
the primary mechanism. True SIADH is rare in heart failure; the mechanism is non-osmotic ADH release
in response to decreased effective arterial volume.




5. A 52-year-old male with a 20-year history of chronic hepatitis C presents with worsening fatigue,
jaundice, and abdominal distension. Physical examination reveals scleral icterus, spider angiomas,
palmar erythema, and a fluid wave. Laboratory studies show total bilirubin 6.2 mg/dL, AST 145 U/L,
ALT 98 U/L, albumin 2.8 g/dL, and INR 1.9. Serum ammonia level is 89 mcg/dL. Which of the
following pathophysiological mechanisms is MOST responsible for the development of hepatic
encephalopathy in this patient with cirrhosis?

A. Accumulation of mercaptans and short-chain fatty acids from impaired hepatic metabolism of
dietary proteins
B. Increased blood-brain barrier permeability to ammonia due to systemic inflammation and oxidative
stress
C. Decreased hepatic clearance of ammonia leading to increased glutamine synthesis in astrocytes and
cerebral edema
D. Impaired urea cycle function due to hepatocellular damage and portosystemic shunting of blood
E. Enhanced GABA-ergic tone from increased endogenous benzodiazepine-like substances in the brain

Correct Answer: D — Impaired urea cycle function due to hepatocellular damage and portosystemic
shunting of blood

Rationale: Hepatic encephalopathy in cirrhosis results from a combination of impaired urea cycle
function (hepatocellular damage) and portosystemic shunting of blood, allowing ammonia and other
neurotoxins from the gut to bypass hepatic metabolism and reach the brain. In the brain, ammonia is
metabolized to glutamine in astrocytes, causing osmotic swelling, cerebral edema, and altered
neurotransmission. The elevated ammonia (89 mcg/dL) is the primary neurotoxin. Mercaptans and
short-chain fatty acids contribute but are less important. Blood-brain barrier permeability is increased
but this is a secondary mechanism. GABA-ergic tone is increased but this is a consequence rather than
the primary mechanism. The presence of jaundice (bilirubin 6.2), low albumin (2.8), and prolonged INR
(1.9) indicates advanced cirrhosis (Child-Pugh B or C). Portal hypertension from cirrhosis leads to
portosystemic shunts (spontaneous or surgical), allowing ammonia to bypass hepatic metabolism.




6. A 65-year-old patient with a history of hypertension and hyperlipidemia presents with acute-
onset, severe, "tearing" chest pain that radiates to the interscapular region. Blood pressure is 180/95
mmHg in the right arm and 130/80 mmHg in the left arm. Heart rate is 110 beats per minute. Which
of the following pathophysiological mechanisms BEST explains the blood pressure differential in
this patient?

Document information

Uploaded on
July 6, 2026
Number of pages
58
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$20.49

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
TopMarkStudyHub
2.5
(2)
Sold
19
Followers
0
Items
2324
Last sold
3 weeks ago


Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions